The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer.
about
Viro-immune therapy: A new strategy for treatment of pancreatic cancerPrognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.Potential targeting of B7-H4 for the treatment of cancer.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.The tissue distribution and significance of B7-H4 in laryngeal carcinoma.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer.The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis.Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma
P2860
Q26774641-6163DD91-54CF-46F1-8C5C-623DBDB53D88Q33688959-14838C31-294C-4632-BC87-4B954FE5DF53Q35543730-AABE3788-B699-4156-8773-11EB5C3D7693Q35983676-C268BE83-EA3D-4262-AA8D-7F907D2834E7Q37718360-4890BB8E-7B8E-4F2C-85BD-0C552258D6D7Q38666253-5C889EA1-C406-4F58-9833-D3BBEF73F586Q38930119-ADF6E03D-C786-4280-B811-BA333CDB2F60Q39160982-829A70C4-EBEA-462A-95D6-619FBE320F18Q41809391-E5F2DBAD-A06F-45A6-B275-E683332E645EQ42104639-C30F35BF-CB25-4339-B0CB-3208DFB4A074Q43058997-FFB16C76-75F4-4FC7-A72F-BB7A0FC3011AQ47102186-3DE8F4B6-04AB-48A6-8344-D58EBE8AB14FQ47150218-FF5DFB7D-4A0B-42A1-9569-42D240097893Q48819240-99BDBE7F-9572-418C-8E4B-2B3F1A8213E4Q50138482-6254217A-FBCD-4E9D-A057-DF9902010E14Q55007801-A7F19EC2-F8D5-4F23-BAAB-FD6C297C8D1EQ55364857-8809E245-7882-4888-952D-846402526CE1Q58129683-E4E98DE1-BACB-445B-8698-7F3E25134356
P2860
The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The coexpression and clinical ...... H4 in human pancreatic cancer.
@ast
The coexpression and clinical ...... H4 in human pancreatic cancer.
@en
The coexpression and clinical ...... H4 in human pancreatic cancer.
@nl
type
label
The coexpression and clinical ...... H4 in human pancreatic cancer.
@ast
The coexpression and clinical ...... H4 in human pancreatic cancer.
@en
The coexpression and clinical ...... H4 in human pancreatic cancer.
@nl
prefLabel
The coexpression and clinical ...... H4 in human pancreatic cancer.
@ast
The coexpression and clinical ...... H4 in human pancreatic cancer.
@en
The coexpression and clinical ...... H4 in human pancreatic cancer.
@nl
P2093
P2860
P356
P1476
The coexpression and clinical ...... H4 in human pancreatic cancer.
@en
P2093
Dongming Zhu
Lifeng Zhang
Qiaoming Zhi
Shiduo Song
Songbing He
Yuting Kuang
P2860
P304
P356
10.2147/OTT.S66809
P407
P577
2014-08-19T00:00:00Z